Mereo Biopharma Group Stock Cash Per Share
| 0A9G Stock | 3.54 0.14 4.12% |
Mereo BioPharma Group fundamentals help investors to digest information that contributes to Mereo BioPharma's financial success or failures. It also enables traders to predict the movement of Mereo Stock. The fundamental analysis module provides a way to measure Mereo BioPharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mereo BioPharma stock.
Mereo | Cash Per Share |
Mereo BioPharma Group Company Cash Per Share Analysis
Mereo BioPharma's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
Mereo Net Income Applicable To Common Shares
Net Income Applicable To Common Shares |
|
In accordance with the recently published financial statements, Mereo BioPharma Group has a Cash Per Share of 0.0 times. This is 100.0% lower than that of the Commercial Services & Supplies sector and about the same as Industrials (which currently averages 0.0) industry. The cash per share for all United Kingdom stocks is 100.0% higher than that of the company.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Mereo Fundamentals
| Return On Equity | -0.74 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (38.07) % | |||
| Current Valuation | 2.53 B | |||
| Shares Owned By Insiders | 1.02 % | |||
| Shares Owned By Institutions | 68.29 % | |||
| Revenue | 1000 K | |||
| Gross Profit | 936 K | |||
| EBITDA | (37.48 M) | |||
| Net Income | (34.2 M) | |||
| Book Value Per Share | 0.47 X | |||
| Cash Flow From Operations | (38.82 M) | |||
| Earnings Per Share | (0.28) X | |||
| Target Price | 4.38 | |||
| Number Of Employees | 33 | |||
| Beta | 0.97 | |||
| Retained Earnings | (331.16 M) |
About Mereo BioPharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mereo BioPharma Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mereo BioPharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mereo BioPharma Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mereo Stock Analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.